{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+gabapentin&page=2", "query": { "intervention": "Placebo gabapentin", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+gabapentin&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T05:29:35.690Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00593463", "title": "Drug Discrimination in Methadone-Maintained Humans Study 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Drug Dependence" ], "interventions": [ { "name": "Cycloserine", "type": "DRUG" }, { "name": "Diltiazem", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" }, { "name": "Isradipine", "type": "DRUG" }, { "name": "Naloxone", "type": "DRUG" }, { "name": "Nifedipine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Saline", "type": "DEVICE" }, { "name": "Verapamil", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of Arkansas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2006-09", "completion_date": "2010-05", "has_results": false, "last_update_posted_date": "2011-03-11", "last_synced_at": "2026-09-28T05:29:35.690Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00593463" }, { "nct_id": "NCT02944656", "title": "Gabapentin as an Adjunct to Paracervical Block for Perioperative Pain Management", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 114, "start_date": "2016-12-08", "completion_date": "2018-06-26", "has_results": true, "last_update_posted_date": "2019-08-08", "last_synced_at": "2026-09-28T05:29:35.690Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02944656" }, { "nct_id": "NCT05064319", "title": "Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bipolar Disorder", "Cannabis Use", "Schizoaffective Disorder, Bipolar Type", "Bipolar I Disorder", "Bipolar II Disorder", "Cannabis Use Disorder, Mild", "Cannabis Use Disorder, Moderate", "Cannabis Use Disorder, Severe" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 51, "start_date": "2022-02-24", "completion_date": "2026-07-31", "has_results": false, "last_update_posted_date": "2026-09-09", "last_synced_at": "2026-09-28T05:29:35.690Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05064319" }, { "nct_id": "NCT00027963", "title": "Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Neurotoxicity", "Pain" ], "interventions": [ { "name": "gabapentin", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2002-02", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2016-07-04", "last_synced_at": "2026-09-28T05:29:35.690Z", "location_count": 22, "location_summary": "Scottsdale, Arizona • Jacksonville, Florida • Peoria, Illinois + 19 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Urbana", "state": "Illinois" }, { "city": "Cedar Rapids", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT00027963" }, { "nct_id": "NCT05319756", "title": "Study Evaluating the Abuse Potential of NEURONTIN® in Healthy Non-drug Dependent, Recreational Opioid Users", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Abuse Potential" ], "interventions": [ { "name": "gabapentin 600 mg", "type": "DRUG" }, { "name": "gabapentin 1200 mg", "type": "DRUG" }, { "name": "gabapentin 600 mg and oxycodone HCl 20 mg", "type": "DRUG" }, { "name": "gabapentin 1200 mg and oxycodone HCl 20 mg", "type": "DRUG" }, { "name": "oxycodone HCl 20 mg", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Viatris Specialty LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 54, "start_date": "2021-04-30", "completion_date": "2021-12-31", "has_results": true, "last_update_posted_date": "2023-08-14", "last_synced_at": "2026-09-28T05:29:35.690Z", "location_count": 1, "location_summary": "Marlton, New Jersey", "locations": [ { "city": "Marlton", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05319756" }, { "nct_id": "NCT00666770", "title": "A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Transient Insomnia" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 309, "start_date": "2004-10", "completion_date": "2004-11", "has_results": false, "last_update_posted_date": "2021-02-02", "last_synced_at": "2026-09-28T05:29:35.690Z", "location_count": 5, "location_summary": "Glendale, California • San Diego, California • Overland Park, Kansas + 1 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00666770" }, { "nct_id": "NCT01301001", "title": "A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vulvodynia" ], "interventions": [ { "name": "Placebo oral capsule", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Tennessee", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 230, "start_date": "2012-08", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-09-28T05:29:35.690Z", "location_count": 3, "location_summary": "New Brunswick, New Jersey • Rochester, New York • Memphis, Tennessee", "locations": [ { "city": "New Brunswick", "state": "New Jersey" }, { "city": "Rochester", "state": "New York" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01301001" }, { "nct_id": "NCT00420771", "title": "Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Benzodiazepine Dependence", "Opioid Dependence" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York State Psychiatric Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 19, "start_date": "2007-01", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2019-04-24", "last_synced_at": "2026-09-28T05:29:35.690Z", "location_count": 1, "location_summary": "Long Island City, New York", "locations": [ { "city": "Long Island City", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00420771" }, { "nct_id": "NCT00028574", "title": "Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hot Flashes", "Prostate Cancer" ], "interventions": [ { "name": "gabapentin", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 223, "start_date": "2001-12", "completion_date": "2007-04", "has_results": false, "last_update_posted_date": "2016-06-28", "last_synced_at": "2026-09-28T05:29:35.690Z", "location_count": 170, "location_summary": "Mobile, Alabama • Washington D.C., District of Columbia • Jacksonville, Florida + 103 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Honolula", "state": "Hawaii" }, { "city": "Honolulu", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT00028574" }, { "nct_id": "NCT00619476", "title": "A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neuralgia, Postherpetic" ], "interventions": [ { "name": "GEn 1200mg/day", "type": "DRUG" }, { "name": "GEn 2400mg/day", "type": "DRUG" }, { "name": "GEn 3600mg/day", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "XenoPort, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 376, "start_date": "2008-02", "completion_date": "2009-07", "has_results": true, "last_update_posted_date": "2013-07-22", "last_synced_at": "2026-09-28T05:29:35.690Z", "location_count": 72, "location_summary": "Birmingham, Alabama • Northport, Alabama • Chandler, Arizona + 65 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Northport", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Litchfield Park", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00619476" } ] }